|
Volumn 43, Issue 1, 2002, Pages 139-143
|
Vascular endothelial growth factor (VEGF) expression in plasmacytoma
|
Author keywords
Angiogenesis; Antiangiogenic therapy; Hemapoietic neoplasia; Multiple myeloma; Plasmacytoma; Prosnosis; VEGF
|
Indexed keywords
VASCULOTROPIN;
BIOLOGICAL MARKER;
ENDOTHELIAL CELL GROWTH FACTOR;
LYMPHOKINE;
SIGNAL PEPTIDE;
VASCULOTROPIN A;
ADULT;
AGED;
ARTICLE;
BONE CANCER;
BONE MARROW CANCER;
CANCER DIAGNOSIS;
CANCER GRADING;
CANCER GROWTH;
CANCER RISK;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MALE;
MATURITY;
MICROMORPHOLOGY;
MICROVASCULATURE;
MYELOMA;
PLASMACYTOMA;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN EXPRESSION;
SCORING SYSTEM;
SOFT TISSUE TUMOR;
STATISTICAL ANALYSIS;
BIOPSY;
BONE MARROW;
CANCER INVASION;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
PROGNOSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
BIOLOGICAL MARKERS;
BIOPSY;
BONE MARROW;
ENDOTHELIAL GROWTH FACTORS;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
LYMPHOKINES;
MALE;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
PLASMACYTOMA;
PROGNOSIS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0036125326
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/10428190210203 Document Type: Article |
Times cited : (16)
|
References (25)
|